Literature DB >> 36262591

Teledermatology Services during COVID-19 Pandemic: Experience of a Tertiary Care center in Western India.

Anupama Bains1, Afroz Alam1, Saurabh Singh1, Anil Budania1, Suman Patra1, Abhishek Bhardwaj1.   

Abstract

Background: Telemedicine has emerged as an important tool in providing patient care during the COVID-19 pandemic. Hence, we aimed to study the clinico-epidemiological profile of patients seen in the teledermatology outpatient department (OPD) during the COVID-19 pandemic. Material and
Methods: Retrospective data analysis of records of patients, who consulted in telemedicine OPD from 20 April 2020 to 5 Feb 2021 was done.
Results: Out of 2524 patients registered for teledermatology consultation, 2117 completed the process of teleconsultation. The mean age of patients was 35.59 ± 15.60 years. There was a male preponderance with 1372 (64.81%) patients while females were 745 (35.19%). 1773 (83.75%) patients were managed on telemedicine alone and 344 (17.42%) patients required face to face physical consultation. The most common disorder was dermatophytosis seen in 316 (17.82%) followed by hair disorders like androgenetic alopecia and telogen effluvium in 239 (13.48%), acne in 238 (13.42%) and dermatitis in 196 (11.05%). Blood investigations were advised in 365 (17.24%) patients and skin biopsy was advised in 23 (1.09%) patients. The major causes for incomplete teleconsultation procedure were no response to telephone calls in 207 (8.2%), 76 (3.01%) patients had taken a prior consultation and 60 (2.37%) patients didn't give consent for teleconsultation.
Conclusion: Common dermatological diseases like tinea, acne, hair disorders and dermatitis can be managed on telemedicine alone. In India, there are fewer dermatologists per population, therefore telemedicine can be continued even after the pandemic is over in cases where diagnoses and treatment are straight forward. Copyright:
© 2022 Indian Dermatology Online Journal.

Entities:  

Keywords:  COVID-19 pandemic; teledermatology; telemedicine

Year:  2022        PMID: 36262591      PMCID: PMC9574130          DOI: 10.4103/idoj.idoj_1_22

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


  13 in total

Review 1.  Teledermatology: A Review and Update.

Authors:  Jonathan J Lee; Joseph C English
Journal:  Am J Clin Dermatol       Date:  2018-04       Impact factor: 7.403

2.  Identifying trends in patient characteristics and visit details during the transition to teledermatology: Experience at a single tertiary referral center.

Authors:  Steven Krueger; Nicholas Leonard; Nicholas Modest; Julie Flahive; Yurima Guilarte-Walker; Mehdi Rashighi; Avery Heather LaChance
Journal:  J Am Acad Dermatol       Date:  2020-11-27       Impact factor: 11.527

3.  Impact of COVID-19 Pandemic on Dermatology Practice in India.

Authors:  Shashank Bhargava; Rashmi Sarkar
Journal:  Indian Dermatol Online J       Date:  2020-09-19

4.  Impact of COVID-19 pandemic on dermatology practices: Results of a web-based, global survey.

Authors:  Shashank Bhargava; Charles McKeever; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2020-10-12

5.  Patient and physician perspectives on teledermatology at an academic dermatology department amid the COVID-19 pandemic.

Authors:  Emmanuella Ngozi Asabor; Christopher G Bunick; Jeffrey M Cohen; Sara H Perkins
Journal:  J Am Acad Dermatol       Date:  2020-09-15       Impact factor: 11.527

6.  Teledermatology during the COVID-19 pandemic: Experience at a tertiary care centre in North India.

Authors:  Sanjeev Handa; Hitaishi Mehta; Anuradha Bishnoi; Keshavamurthy Vinay; Rahul Mahajan; Tarun Narang; Muthu Sendhil Kumaran; Dipankar De; Sunil Dogra; Davinder Parsad
Journal:  Dermatol Ther       Date:  2021-06-14       Impact factor: 3.858

7.  WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): from bedside to phone-side.

Authors:  D Jakhar; S Kaul; I Kaur
Journal:  Clin Exp Dermatol       Date:  2020-05-02       Impact factor: 4.481

8.  Will teledermatology be the silver lining during and after COVID-19?

Authors:  Aseem Sharma; Veenu Jindal; Palvi Singla; Mohamad Goldust; Madhulika Mhatre
Journal:  Dermatol Ther       Date:  2020-06-04       Impact factor: 3.858

9.  Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic.

Authors:  C Marasca; A Ruggiero; G Fontanella; M Ferrillo; G Fabbrocini; A Villani
Journal:  Clin Exp Dermatol       Date:  2020-05-28       Impact factor: 3.470

10.  Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during COVID-19 emergency in a tertiary center in Italy.

Authors:  Alexandra Maria Giovanna Brunasso; Cesare Massone
Journal:  Dermatol Ther       Date:  2020-06-22       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.